Tech Company Financing Transactions
Shenzhen Wingor Biotechnology Funding Round
Shenzhen Wingor Biotechnology secured a venture capital round on 8/25/2025. Investors included KC Investments Group and private investors.
Transaction Overview
Company Name
Announced On
8/25/2025
Transaction Type
Amount
Unknown
Round
Undisclosed
Investors
KC Investments Group (Lead Investor) (Kent Cai)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3rd Floor, Building 1, Nantai Cloud Innovation Valley, Guang
Shenzhen, Guangdong, Undisclosed
China
Shenzhen, Guangdong, Undisclosed
China
Phone
Website
Email Address
Not Recorded
Overview
Shenzhen Yinguan Biotechnology Co., Ltd. is a high-tech enterprise dedicated to the field of cell and gene therapy, focusing on innovative stem cell drugs and combination therapies. The company integrates research, development, translation, and application. It has received strategic investment from Oriental Fortune GP, a sub-fund of the Shenzhen Municipal Government Guidance Fund, Hanshang Group (600774.SH), and Meri Health International (02327.HK)
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jiang Shu
Browse more venture capital transactions:
Prev: 8/24/2025: Applied Value venture capital transaction
Next: 8/25/2025: Dirac venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs